<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03542721</url>
  </required_header>
  <id_info>
    <org_study_id>DA-5515</org_study_id>
    <nct_id>NCT03542721</nct_id>
  </id_info>
  <brief_title>Effect of DA-5515 (Circulan® Soft Cap.) in Patients With Chronic Fatigue Symptoms Due to Impaired Blood Circulation</brief_title>
  <official_title>A Placebo-controlled, Randomized, Double-blind, Parallel, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of DA-5515 (Circulan® Soft Cap.) in Patients With Chronic Fatigue Symptoms Due to Impaired Blood Circulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dong-A Pharmaceutical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dong-A Pharmaceutical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present clinical study is to evaluate the efficacy and safety of the DA-5515
      (Circulan Soft Cap.) in patients with chronic fatigue symptoms due to impaired blood
      circulation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is conducting to assess the efficacy and safety of the DA-5515 (Circulan Soft
      Cap.), which has been known to have a fatigue recovery effect due to impaired blood
      circulation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 17, 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CIS(Checklist Individual Strength) less than or equal to 76</measure>
    <time_frame>8weeks</time_frame>
    <description>Rate of subjects whose CIS score has improved less than or equal to 76 at 8weeks</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">204</enrollment>
  <condition>Fatigue Symptom</condition>
  <arm_group>
    <arm_group_label>Placebo of DA-5515 Capsule</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo of DA-5515 (three times a day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DA-5515 Capsule</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Garlic oil, Gingko biloba ex.,Crataegus berry ex.,Melissa officinalis ex., (three times a day)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DA-5515</intervention_name>
    <description>Crataegi ethanol extract, Garlic oil, Ginkgo leaf extract, Melissa folium extract (three times a day)</description>
    <arm_group_label>DA-5515 Capsule</arm_group_label>
    <other_name>Circulan® Soft Capule</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo of DA-5515</intervention_name>
    <description>Placebo (three times a day)</description>
    <arm_group_label>Placebo of DA-5515 Capsule</arm_group_label>
    <other_name>Placebo capsule</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Rutherford's category 0/0 or Ⅰ/1

          -  ABI &lt;1.0

          -  CIS greater than 76

          -  HADS less than or equal to 10

          -  Subjects who have fatigue symptoms more than 1 month

        Exclusion Criteria:

          -  Subjects who have diseases that can cause fatigue

          -  Subjects who are taking medication that can cause fatigue
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>WhanSeok Choi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul St. Mary's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ran Seo</last_name>
    <phone>010-4547-1480</phone>
    <email>seoran@dreamwiz.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>WhanSeok Choi</last_name>
    <phone>02-2258-6285</phone>
    <email>fmchs@catholic.ac.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ran Seo</last_name>
      <phone>010-4547-1480</phone>
      <email>seoran@dreamwiz.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>May 18, 2018</study_first_submitted>
  <study_first_submitted_qc>May 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2018</study_first_posted>
  <last_update_submitted>June 1, 2018</last_update_submitted>
  <last_update_submitted_qc>June 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic fatigue symptom</keyword>
  <keyword>blood circulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

